Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis.
Sparrow, Miles
(Primary Chief Investigator (PCI))
Medicine Alfred Hospital
Project
:
Research
Overview
Project Details
Status
Finished
Effective start/end date
28/08/19
→
31/12/21
View all
View less
Keywords
Gastroenterology
Ulcerative colitis
Clinical trial